Company: VEEAW
Filing Date: 2025-07-07
Form Type: DRS
Source: 0001213900-25-061586
Chunk: 92

Company: VEEA INC.
Filing Date: 2025-07-07
Form: DRS
Chunk 92
---
 Forma   
 As Adjusted |      |   |
|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:----|:-------|:-----|:----|:----------|:-----|:----|:------------|:-----|:--|
| Cash and cash equivalents                                                                                                                                                                                                                                            |     | $      | [__] |     | $         | [__] |     | $           | [__] |   |
| Notes Payable                                                                                                                                                                                                                                                        |     |        | [__] |     |           | [__] |     |             | [__] |   |
| Stockholders’ equity (deficit):                                                                                                                                                                                                                                      |     |        |      |     |           |      |     |             |      |   |
| Common stock, par value $0.0001 per share: 551,000,000 shares authorized as of March 31, 2025; 36,475,884 shares issued and outstanding as of March 31, 2025; [__] shares issued and outstanding pro forma; [__]shares issued and outstanding pro forma as adjusted; |     |        | [__] |     |           | [__] |     |             | [__] |   |
| Additional paid-in capital                                                                                                                                                                                                                                           |     |        | [__] |     |           | [__] |     |             | [__] |   |
| Accumulated deficit                                                                                                                                                                                                                                                  |     |        | [__] |     |           | [__] |     |             | [__] | ) |
| Total stockholders’ equity (deficit)                                                                                                                                                                                                                                 |     |        | [__] |     |           | [__] |     |             | [__] |   |
| Total capitalization                                                                                                                                                                                                                                                 |     | $      | [__] |     | $         | [__] |     | $           | [__] |   |

A $0.25 increase or decrease
in the assumed public offering price of $[__] per share, which was the closing price of our common stock as reported on Nasdaq on [__],
2025, would increase or decrease, respectively, our pro forma as adjusted cash and cash equivalents, additional paid-in capital, total
stockholders’ equity, and total capitalization by approximately $[__], assuming the number of the securities offered by us, as set
forth on the cover page of this prospectus, remains the same, assuming no sale